CI Investments Inc
EW icon

CI Investments Inc’s Edwards Lifesciences EW Stock Holding History

CI Investments Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
33,650
+17,708
+111% +$1.48M 0.01% 411
2026
Q1 		$1.28M Sell
15,942
-1,052
-6% -$86.7K 0.01% 409
2025
Q4 		$1.45M Buy
16,994
+896
+6% +$73.5K 0.01% 398
2025
Q3 		$1.25M Sell
16,098
-1,692
-10% -$132K ﹤0.01% 403
2025
Q2 		$1.39M Sell
17,790
-5,821
-25% -$434K 0.01% 387
2025
Q1 		$1.71M Sell
23,611
-2,733
-10% -$196K 0.01% 373
2024
Q4 		$1.95M Buy
26,344
+4,773
+22% +$334K 0.01% 359
2024
Q3 		$1.42M Sell
21,571
-143,640
-87% -$10.4M 0.01% 376
2024
Q2 		$15.3M Sell
165,211
-4,056
-2% -$359K 0.06% 187
2024
Q1 		$16.2M Sell
169,267
-387,555
-70% -$32.6M 0.06% 191
2023
Q4 		$42.5M Sell
556,822
-79,886
-13% -$5.56M 0.22% 102
2023
Q3 		$44.1M Sell
636,708
-727,660
-53% -$58.5M 0.25% 96
2023
Q2 		$129M Sell
1,364,368
-385,525
-22% -$33.5M 0.65% 44
2023
Q1 		$145M Sell
1,749,893
-611,515
-26% -$48.1M 0.73% 37
2022
Q4 		$176M Buy
2,361,408
+118,622
+5% +$9.14M 0.89% 31
2022
Q3 		$185M Buy
2,242,786
+367,869
+20% +$35.4M 0.96% 25
2022
Q2 		$178M Sell
1,874,917
-216,981
-10% -$22.5M 0.83% 28
2022
Q1 		$246M Buy
2,091,898
+536,324
+34% +$60.2M 0.91% 22
2021
Q4 		$202M Buy
1,555,574
+257,065
+20% +$30M 0.7% 36
2021
Q3 		$147M Buy
1,298,509
+8,360
+0.6% +$954K 0.55% 52
2021
Q2 		$134M Buy
1,290,149
+606,536
+89% +$57.2M 0.49% 58
2021
Q1 		$57.2M Buy
683,613
+225,560
+49% +$19.1M 0.24% 115
2020
Q4 		$41.8M Buy
458,053
+53,988
+13% +$4.48M 0.18% 137
2020
Q3 		$32.3M Buy
404,065
+403,297
+52,513% +$31.5M 0.16% 131
2020
Q2 		$53K Buy
+768
New +$54.6K ﹤0.01% 602
2020
Q1 		– Sell
-7,494
Closed -$583K – 585
2019
Q4 		$583K Buy
7,494
+12
+0.2% +$937 ﹤0.01% 410
2019
Q3 		$548K Buy
+7,482
New +$526K ﹤0.01% 450

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CI Investments Inc's EW Position: Q2 2026 in Review

CI Investments Inc increased its Edwards Lifesciences (EW) stake by 111% in Q2 2026, buying an estimated $1.48M and bringing the position to 33,650 shares worth $3.04M. The position accounts for 0.01% of the portfolio, ranked #411.

CI Investments Inc first reported a position in EW in Q3 2019 and has held it in 27 quarters since. The position peaked at $246M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • CI Investments Inc held 33,650 shares of Edwards Lifesciences worth $3.04M as of Q2 2026.
  • CI Investments Inc bought 17,708 Edwards Lifesciences shares in Q2 2026, an estimated $1.48M.
  • Edwards Lifesciences made up 0.01% of CI Investments Inc's portfolio in Q2 2026, its #411 holding.
  • CI Investments Inc first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 27 quarters since.
  • CI Investments Inc's Edwards Lifesciences position peaked at $246M in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.